tigecycline Type of group
Sponsors
LABORATORIOS WYETH S.A.,
Early Phase 1
Unknown Phase
STUDY PHASE III, RANDOM, DOUBLE BLIND AND COMPARATIVE INTENDED TO EVALUATE THE EFFICACY AND SAFETY OF TIGECICLINE COMPARED TO LEVOFLOXACIN IN THE TREATMENT OF PATIENTS HOSPITALIZED WITH PNEUMONIA ACQUIRED IN THE COMMUNITY OF DATE APRIL 1, 2003
PER-025-04
Target: 8Updated: 2023-09-04
PHASE 3, MULTICENTER, RANDOM, DOUBLE-BLIND AND COMPARATIVE STUDY DESIGNED TO ASSESS THE EFFICACY AND SAFETY OF TIGECICLINE COMPARED TO LEVOFLOXACIN IN THE TREATMENT OF PATIENTS HOSPITALIZED WITH PNEUMONIA ACQUIRED IN THE COMMUNITY.
Active, not recruitingPER-043-04
Updated: 2023-09-04